Vis enkel innførsel

dc.contributor.authorWisløff, Torbjørn
dc.contributor.authorWhite, Richard Aubrey
dc.contributor.authorDalgard, Olav
dc.contributor.authorAmundsen, Ellen Johanna
dc.contributor.authorMeijerink, Hinta
dc.contributor.authorLøvlie, Astrid Louise
dc.contributor.authorKløvstad, Hilde
dc.date.accessioned2018-07-30T12:32:39Z
dc.date.available2018-07-30T12:32:39Z
dc.date.created2018-04-25T14:32:06Z
dc.date.issued2018
dc.identifier.citationPharmacoEconomics (Auckland). 2018, 36 (5), 591-601.
dc.identifier.issn1170-7690
dc.identifier.urihttp://hdl.handle.net/11250/2506827
dc.language.isoeng
dc.relation.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906515/
dc.titleEconomic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber591-601
dc.source.volume36
dc.source.journalPharmacoEconomics (Auckland)
dc.source.issue5
dc.identifier.doi10.1007/s40273-017-0604-3
dc.identifier.cristin1581614
cristin.unitcode7502,4,19,0
cristin.unitcode7502,3,4,0
cristin.unitcode7502,4,20,0
cristin.unitcode7502,4,12,0
cristin.unitnameInfeksjonsepidemiologi og modellering
cristin.unitnameRusmiddelbruk
cristin.unitnameSmittevernregistre
cristin.unitnameTuberkulose, blod- og seksuell smitte
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel